Paper11905830
Strategies for designing and optimizing new generation vaccines.
Berzofsky JA and 2 others. Nat Rev Immunol, 2001. Cited by 263 papers, by iCite.
Cite this record
ConductScience Library. Strategies for designing and optimizing new generation vaccines. Papers, record 11905830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11905830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vaccines | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| Cytokines | |
| Dendritic Cells | |
| Drug Design | |
| Epitopes | |
| Humans | |
| Immunity, Mucosal | |
| Models, Immunological | |
| T-Lymphocytes, Cytotoxic | |
| Vaccines, DNA |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00972309 | A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer | Background |
Source ClinicalTrials.gov
References171
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10727437 | Dendritic cells: at the clinical crossroads. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10727437 | PubMed |
| 2 | 11313372 | Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. | J Immunol | 2001 | https://conductscience.org/library/papers/11313372 | PubMed |
| 3 | 8551248 | Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. | J Exp Med | 1996 | https://conductscience.org/library/papers/8551248 | PubMed |
| 4 | 11733563 | High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11733563 | PubMed |
| 5 | 10099122 | Mucosal immune system of the human genital tract. | J Infect Dis | 1999 | https://conductscience.org/library/papers/10099122 | PubMed |
| 6 | 9632982 | The gastrointestinal tract and the pathogenesis of AIDS. | AIDS | 1998 | https://conductscience.org/library/papers/9632982 | PubMed |
| 7 | 11313385 | Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. | J Immunol | 2001 | https://conductscience.org/library/papers/11313385 | PubMed |
| 8 | 8104103 | Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. | Cell | 1993 | https://conductscience.org/library/papers/8104103 | PubMed |
| 9 | 9774275 | Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. | Science | 1998 | https://conductscience.org/library/papers/9774275 | PubMed |
| 10 | 1545867 | Genetic immunization is a simple method for eliciting an immune response. | Nature | 1992 | https://conductscience.org/library/papers/1545867 | PubMed |
| 11 | 11325845 | Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells. | Cancer Res | 2001 | https://conductscience.org/library/papers/11325845 | PubMed |
| 12 | 9234241 | Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. | Mol Med | 1997 | https://conductscience.org/library/papers/9234241 | PubMed |
| 13 | 9541605 | Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. | Eur J Immunol | 1998 | https://conductscience.org/library/papers/9541605 | PubMed |
| 14 | 7566090 | Induction of apoptosis in mature T cells by tumour necrosis factor. | Nature | 1995 | https://conductscience.org/library/papers/7566090 | PubMed |
| 15 | 8665591 | Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. | Cell Immunol | 1996 | https://conductscience.org/library/papers/8665591 | PubMed |
| 16 | 8097319 | Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8097319 | PubMed |
| 17 | 10837079 | DNA vaccines: immunology, application, and optimization*. | Annu Rev Immunol | 2000 | https://conductscience.org/library/papers/10837079 | PubMed |
| 18 | 11208869 | Differentiation of T regulatory cells by immature dendritic cells. | J Exp Med | 2001 | https://conductscience.org/library/papers/11208869 | PubMed |
| 19 | 11238120 | Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. | Blood | 2001 | https://conductscience.org/library/papers/11238120 | PubMed |
| 20 | 11257389 | Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. | Vaccine | 2001 | https://conductscience.org/library/papers/11257389 | PubMed |
Cited by99
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41736107 | Programmable trivalent nanocage vaccine confers durable cross-species protection against Bordetella bronchiseptica infection. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41736107 | PubMed |
| 40872750 | Primary Sequence-Intrinsic Immune Evasion by Viral Proteins Guides CTL-Based Vaccine Strategies. | Viruses | 2025 | https://conductscience.org/library/papers/40872750 | PubMed |
| 40733673 | ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40733673 | PubMed |
| 40213668 | Designing multifunctional recombinant vaccines: an engineering strategy based on innovative epitope prediction-guided splicing. | Theranostics | 2025 | https://conductscience.org/library/papers/40213668 | PubMed |
| 39275069 | Self-Assembled Ferritin Nanoparticles for Delivery of Antigens and Development of Vaccines: From Structure and Property to Applications. | Molecules | 2024 | https://conductscience.org/library/papers/39275069 | PubMed |
| 38140232 | Challenges and Opportunities in the Process Development of Chimeric Vaccines. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38140232 | PubMed |
| 37768503 | Peptide-Based Therapeutics in Cancer Therapy. | Mol Biotechnol | 2024 | https://conductscience.org/library/papers/37768503 | PubMed |
| 35550001 | Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design. | Pathog Glob Health | 2023 | https://conductscience.org/library/papers/35550001 | PubMed |
| 34451945 | Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34451945 | PubMed |
| 32961248 | Promotion of CTL epitope presentation by a nanoparticle with environment-responsive stability and phagolysosomal escape capacity. | J Control Release | 2020 | https://conductscience.org/library/papers/32961248 | PubMed |
| 31969886 | High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence. | Front Immunol | 2019 | https://conductscience.org/library/papers/31969886 | PubMed |
| 31457034 | Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications. | Iran J Biotechnol | 2018 | https://conductscience.org/library/papers/31457034 | PubMed |
| 30873164 | Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani. | Front Immunol | 2019 | https://conductscience.org/library/papers/30873164 | PubMed |
| 30524907 | Trial watch: Peptide-based vaccines in anticancer therapy. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/30524907 | PubMed |
| 30019620 | An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells. | Cell Cycle | 2018 | https://conductscience.org/library/papers/30019620 | PubMed |
| 29290804 | An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells. | Theranostics | 2018 | https://conductscience.org/library/papers/29290804 | PubMed |
| 29231862 | Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective. | Molecules | 2017 | https://conductscience.org/library/papers/29231862 | PubMed |
| 29143114 | Cancer vaccine strategies: translation from mice to human clinical trials. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/29143114 | PubMed |
| 28644608 | Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy. | Bioconjug Chem | 2017 | https://conductscience.org/library/papers/28644608 | PubMed |
| 28432083 | Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production. | J Leukoc Biol | 2017 | https://conductscience.org/library/papers/28432083 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11905830
GET https://conductscience.org/api/papers/v1/11905830/references?page=2